Altre lingue IPH Limited

Azioni

Tempo differito Australian S.E. Altri mercati azionari 07:48:41 03/05/2024			Variaz. 5gg	Var. 1 gen.
6,135 ^AUD	+0,08%		-1,21%	-4,29%

29/02	IPH Limited annuncia cambiamenti esecutivi	CI
28/02	L'amministratore delegato di IPH vende le azioni dell'azienda	MT

IPH Limited Announces Executive Changes	29/02
IPH Managing Director Pares Shareholding in Firm	28/02
IPH Reports H1 FY24 Revenue Up 22%, EPS of AU$0.0879	21/02
IPH Ltd. Reports H1 FY24 Revenue Up 21% to AU$274.4 Million; Underlying Diluted EPS of AU$0.212	21/02
IPH Limited Reports Earnings Results for the Half Year Ended December 31, 2023	21/02
US FDA Ends Partial Clinical Hold on Innate Pharma's Investigational Cancer Drug	04/01
Sanofi Licenses Natural Killer Cell Engager Program from Innate Pharma	19/12
IPH Completes ROBIC Business Acquisition	18/12
IPH Limited completed the acquisition of ROBIC L.L.P.	15/12
IPH Announces Third Canadian Acquisition with AU$124 Million Deal	22/11
IPH Managing Director and CEO Sells Company Shares	22/11
IPH Limited entered into an agreement to acquire ROBIC L.L.P. for CAD 110 million.	20/11
IPH Limited Approves Election of Director, David Wiadrowski	15/11
IPH Limited Seeks Acquisitions	15/11
IPH Completes AU$75 Million Acquisition of Canadian IP Services Firm	02/10/23
Australia Inc roiled by string of cyber attacks since late 2022	29/09/23
IPH's Net Profit Jumps 23% in Fiscal Year 2023; Shares Rally 10%	17/08/23
IPH Limited Seeks Acquisitions	17/08/23
IPH Limited Reports Earnings Results for the Full Year Ended June 30, 2023	17/08/23
IPH Limited Declares Final Dividend for the Fiscal Year 2023, Payable on 15 September 2023	17/08/23

Non ci sono risultati per questa ricerca